Drugmaker AbbVie expects Humira volume erosion to worsen
AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as patients shift to other drugs.
AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as patients shift to other drugs.
Zach Klaassen is joined by Chandler Park and Ryan Malone to explore the collaborative approach between GU medical oncology and urology in managing metastatic hormone-sensitive…
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
China lifted the risk alert warning on bird flu in Serbia, the General Administration of Customs announced on Tuesday.
In this webinar, our panelists will discuss recent developments and challenges for adoptive cell therapies for cancer treatment. Our spea…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
Asthma causes one’s airways to become sore and swollen. An attack means a person’s lungs are getting less air. Learn about two types of treatment.
Andrew Goldstein discusses his group’s publication in Cell Reports, focusing on the role of MYC in metabolic changes induced by androgen receptor (AR) inhibition in…
Australia’s CSL , the world’s largest producer of blood plasma products, is trialling “dynamic pricing” of payments to donors to grow profit margins amid persistently…
India’s generic drugmaker Dr Reddy’s Laboratories reported fourth-quarter profit above expectations on Tuesday, driven by strong sales in its key U.S. and European markets.
Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid…